How many stocks are there of Esperite?
The current number of stocks of Esperite is 13.7 M undefined.
Esperite Stocks 2025
Esperite Stocks
13.7 M
Ticker
ESP.AS
ISIN
NL0009272137
In 2025, Esperite had 13.7 M outstanding stocks, a 32.23% change from the 10.36 M stocks in the previous year.
The Esperite Stocks history
| YEAR | NUMBER OF STOCKS (undefined EUR) |
|---|---|
| 2017 | 13.7 |
| 2016 | 10.36 |
| 2015 | 10.03 |
| 2014 | 9.73 |
| 2013 | 9.26 |
| 2012 | 9.34 |
| 2011 | 9.3 |
| 2010 | 9.27 |
| 2009 | 9.24 |
| 2008 | 9.39 |
| 2007 | 7.53 |
| 2006 | 9.64 |
| 2005 | 9.64 |
| 2004 | 9.64 |
Esperite shares outstanding NL0009272137 ·
3 years
5 years
10 years
25 Years
Max
Number of stocks
Details
Revenue, EBIT and Earnings per share
ⓘRevenue Per Share
Revenue per share represents the total revenue Esperite earns, divided by the number of outstanding shares. It is a crucial metric as it reflects the company's ability to generate sales and signifies growth and expansion potential. Comparing yearly revenue per share allows investors to analyze the consistency in a company’s earnings and predict future trends.
EBIT Per Share
EBIT per share indicates Esperite's earning before interest and taxes, offering insights into operational profitability excluding the effects of capital structure and tax rates. It can be juxtaposed against revenue per share to gauge the efficiency in converting sales into profits. A consistent increase in EBIT per share over the years underscores operational efficiency and profitability.
Income Per Share
Income per share, or earnings per share (EPS), reveals the portion of Esperite’s profit allocated to each share of common stock. It’s instrumental in evaluating the profitability and financial health. By comparing it with revenue and EBIT per share, investors discern how effectively a firm translates sales and operational profits into net income.
Expected Values
Expected values are projections of revenue, EBIT, and income per share for forthcoming years. These anticipations, rooted in historical data and market analysis, aid investors in strategizing their investments, evaluating Esperite's prospective performance, and estimating future stock prices. However, it’s pivotal to consider market volatilities and uncertainties that can influence these projections.
| Number of stocks | |
|---|---|
| 2004 | 9.64 M Aktien |
| 2005 | 9.64 M Aktien |
| 2006 | 9.64 M Aktien |
| 2007 | 7.53 M Aktien |
| 2008 | 9.39 M Aktien |
| 2009 | 9.24 M Aktien |
| 2010 | 9.27 M Aktien |
| 2011 | 9.3 M Aktien |
| 2012 | 9.34 M Aktien |
| 2013 | 9.26 M Aktien |
| 2014 | 9.73 M Aktien |
| 2015 | 10.03 M Aktien |
| 2016 | 10.36 M Aktien |
| 2017 | 13.7 M Aktien |
Esperite Aktienanalyse
What does Esperite do?
Esperite NV is a company based in the Netherlands that specializes in the development, production, and marketing of stem cell and cell therapies. It focuses on creating groundbreaking therapies for the treatment of serious diseases and aims to market them worldwide. Its business model includes three main segments: Life Science, Consumer Healthcare, and Branding. The Life Science segment focuses on developing stem cell and cell therapies for the treatment of diseases such as autism, cancer, and degenerative disorders. The Consumer Healthcare segment offers products related to pregnancy and fertility assistance. The Branding segment involves the development and marketing of high-quality cosmetic products. Esperite's flagship product is CryoSave, a solution for the long-term preservation of stem cells from umbilical cord blood. Esperite ist eines der beliebtesten Unternehmen auf Eulerpool.com.Stocks Details
Evaluating Esperite's Shares Outstanding
Esperite's shares outstanding refer to the total number of shares that are currently held by all its shareholders, including institutional investors and restricted shares held by the company’s officers and insiders. The number of shares outstanding is crucial in determining the company's market capitalization and is used by investors to assess the company’s size, financial health, and investment potential.
Year-to-Year Comparison
Tracking the changes in Esperite’s shares outstanding over the years can provide investors with insights into the company's financial strategies and market valuation. An increase in shares outstanding can result from actions like issuing new shares, while a decrease can result from buybacks.
Impact on Investments
For investors, understanding Esperite’s shares outstanding is essential for evaluating its earnings per share (EPS) and market valuation. A change in the number of shares outstanding can impact the EPS, which is a significant driver of stock prices and investor decisions.
Interpreting Changes in Shares Outstanding
Variances in Esperite’s shares outstanding can signal shifts in the company’s financial strategy. An increase may dilute the EPS and share value, indicating potential fundraising or acquisitions. Conversely, a decrease, often due to share buybacks, can enhance share value and indicate the company’s confidence in its financial performance.
Frequently Asked Questions about Esperite stock
What does Number of Shares / OutstandingShares mean?
The outstanding shares (or issued shares) of Esperite are the total number of shares issued and actively held by shareholders - both external investors and company insiders. However, these must be actual shares. may grant stock options to executives that can be converted into shares.
How has the number of shares of Esperite evolved in recent years?
The number of shares of Esperite has increased by 32.23% gestiegen compared to last year.
What does the number of shares mean for investors?
The number of shares outstanding is used to calculate key metrics such as a company's market capitalization, earnings per share (EPS), and cash flow per share (CFPS). The number of outstanding shares of a company is not static and can fluctuate greatly over time.
Why does the number of stocks fluctuate?
There are various factors that can lead to a change. Esperite as a company can issue new shares, carry out stock splits or reverse splits.
Does the number of shares have an impact on the performance of Esperite?
There is no tangible long-term evidence or study that stocks with a certain number of shares (regardless of Mega/Large/Mid/Small Cap) would yield significantly higher returns than others. There are occasional small studies (limited number of stocks, short investment period) that certain classes outperform or have higher risk, but none of them are 1. conclusive (cause-effect is unclear, experiment is not repeatable) or 2. generalizable (generalization is not possible due to small sample size and time period).
How much dividend does Esperite pay?
Over the past 12 months, Esperite paid a dividend of 0.08 EUR . This corresponds to a dividend yield of about 869.57 %. For the coming 12 months, Esperite is expected to pay a dividend of 0 EUR.
What is the dividend yield of Esperite?
The current dividend yield of Esperite is 869.57 %.
When does Esperite pay dividends?
Esperite pays a quarterly dividend. This is distributed in the months of .
How secure is the dividend of Esperite?
Esperite paid dividends every year for the past 0 years.
What is the dividend of Esperite?
For the upcoming 12 months, dividends amounting to 0 EUR are expected. This corresponds to a dividend yield of 0 %.
In which sector is Esperite located?
Esperite is assigned to the 'Health' sector.
Wann musste ich die Aktien von Esperite kaufen, um die vorherige Dividende zu erhalten?
To receive the latest dividend of Esperite from 6/14/2012 amounting to 0.08 EUR, you needed to have the stock in your portfolio before the ex-date on 5/18/2012.
When did Esperite pay the last dividend?
The last dividend was paid out on 6/14/2012.
What was the dividend of Esperite in the year 2024?
In the year 2024, Esperite distributed 0 EUR as dividends.
In which currency does Esperite pay out the dividend?
The dividends of Esperite are distributed in EUR.
Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.
Andere Kennzahlen von Esperite
Our stock analysis for Esperite Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Esperite Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.
